TransMedics Group, Inc.
NASDAQTransMedics Group closed Tuesday at $80.75, up 5.8% on the week — but that headline gain masks a more complicated story. Analysts filed a wave of target-price cuts within hours of the company reporting earnings on August 4, even as the stock held its ground. The Street's direction of travel is decisively lower on price targets, though not on conviction. Piper Sandler trimmed its…
Snapshot as of 6 Aug 2026
TransMedics Group closed Tuesday at $80.75, up 5.8% on the week — but that headline gain masks a more complicated story. Analysts filed a wave of target-price cuts within hours of the company reporting earnings on…
TransMedics Group enters the final stretch before its July 31 earnings report with short sellers in control, the stock down 10% on the week, and a Street consensus that still sees the shares at roughly double the…
TransMedics Group enters the post-earnings stretch with a battered share price and a wave of sharply lower analyst price targets rewriting the bull case. The catalyst was immediate. The stock fell 6.3% on the week to…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for TMDX — free to start on ORTEX.
Sign up for free →Open TMDX on ORTEX